Cytodyn Inc (CYDY)

[MelsDollars]

I agree Mister Money. All small pre revenue biotechs have challenges. Most drugs go through many trials before full approval. The only thing different this time was everyone expected more guidance and support from the FDA due to the pandemic. We saw how they approved Remdesivir in record time with only weak data and expected that they would help bring other promising drugs forward. That didn't happen, at least not for the critical population. Fauci and Remdesivir still reign supreme. I'm so glad that the company pivoted to overseas. I support the current board and will continue to do so as progress is being made.